Epigenomics AG (EPGNF)
2.50
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
Epigenomics Profit Margin (Quarterly): -3.76K% for June 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -3.76K% |
| March 31, 2023 | -4.17K% |
| December 31, 2022 | -6.57K% |
| September 30, 2022 | -1.08K% |
| June 30, 2022 | -1.03K% |
| March 31, 2022 | -2.31K% |
| December 31, 2021 | -959.7% |
| September 30, 2021 | 48.90% |
| June 30, 2021 | -1.99K% |
| March 31, 2021 | -1.13K% |
| December 31, 2020 | -856.1% |
| September 30, 2020 | -1.26K% |
| June 30, 2020 | -4.06K% |
| March 31, 2020 | -1.25K% |
| December 31, 2019 | -2.52K% |
| September 30, 2019 | -1.54K% |
| June 30, 2019 | -1.26K% |
| March 31, 2019 | -911.8% |
| December 31, 2018 | -1.81K% |
| September 30, 2018 | -546.7% |
| June 30, 2018 | -552.8% |
| March 31, 2018 | -1.04K% |
| December 31, 2017 | -264.8% |
| September 30, 2017 | -329.2% |
| June 30, 2017 | -1.67K% |
| Date | Value |
|---|---|
| March 31, 2017 | -843.4% |
| December 31, 2016 | -67.66% |
| September 30, 2016 | -270.6% |
| June 30, 2016 | -261.5% |
| March 31, 2016 | -1.47K% |
| December 31, 2015 | -125.6% |
| September 30, 2015 | -511.9% |
| June 30, 2015 | -504.9% |
| March 31, 2015 | -862.1% |
| December 31, 2014 | -715.5% |
| September 30, 2014 | -648.6% |
| June 30, 2014 | -450.1% |
| March 31, 2014 | -550.4% |
| December 31, 2013 | -347.5% |
| September 30, 2013 | -713.7% |
| June 30, 2013 | -477.8% |
| March 31, 2013 | -483.4% |
| December 31, 2012 | -757.5% |
| September 30, 2012 | -1.36K% |
| June 30, 2012 | -2.17K% |
| March 31, 2012 | -962.1% |
| December 31, 2011 | -2.49K% |
| September 30, 2011 | -1.87K% |
| June 30, 2011 | -827.2% |
| March 31, 2011 | -465.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.57K%
Minimum
Dec 2022
48.90%
Maximum
Sep 2021
-2.10K%
Average
-1.26K%
Median
Jun 2019
Profit Margin (Quarterly) Benchmarks
| Affimed NV | -4.89K% |
| InflaRx NV | -26.80K% |
| MorphoSys AG | 81.70% |
| BioNTech SE | -168.0% |
| Immatics NV | -10.09% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -174.3% |
| Return on Assets | -115.8% |
| Return on Invested Capital | -174.3% |
| Gross Profit Margin (Quarterly) | 92.86% |
| Operating Margin (Quarterly) | -3.96K% |
| Return on Net Operating Assets | -323.9% |